Table II.
Description of included abstracts
| Author-year | Type of study | Control | No. of hips in the PRP group | Male/ female | Mean age | Diagnostic test | Duration of symptoms | Mean FU | Outcome measures |
|---|---|---|---|---|---|---|---|---|---|
| Blucher et al. 2015 [33] | Case series | N/A | 85 | 1:4 | 60 | MRI/US | Minimum 3 months | Not reported | EQ-5D, VAS, HOOS |
| Monto 2014 [34] | RCT | Steroid injection | 20 | 5:15 | 66 | MRI/US | 11 months | 12 months | HHS, WOMAC |
| Rajeev et al. 2016 [35] | Case series | N/A | 32 | 12:20 | 76.2 | Not reported | Minimum 6 months | 12 months | HHS, VAS |
| LaSalle et al. 2013 [36] | Case series | N/A | 10 | 1:9 | 64.7 | MRI | 12 weeks | 10.2 months | VAS, NASS, FRI |